Keil René, Kiessling Christina, Hatzfeld Mechthild
Institute for Pathophysiology, Division of Pathobiochemistry, Martin-Luther-University Halle, 06114 Halle, Germany.
J Cell Sci. 2009 Apr 15;122(Pt 8):1174-83. doi: 10.1242/jcs.045377.
P0071 (plakophilin-4) is a member of the p120ctn subfamily of armadillo proteins that are essential for cell contact formation. Additionally, p0071 plays a role in cytokinesis, in which it regulates local activation of RhoA together with Ect2. Because spatiotemporal regulation is required for progression through cytokinesis, we analyzed when and how p0071 is targeted to the midbody to induce RhoA activation. We show that Ect2 precedes p0071 accumulation at the midbody and that targeting is mediated by different motor proteins. p0071 interacted with the kinesin-II family member KIF3b, and knockdown of KIF3b interfered with p0071 midbody recruitment whereas Ect2 or RhoA localization was not affected in these cells. Moreover, knockdown of KIF3b induced a similar phenotype as the p0071 knockdown, with reduced actin and phospho-myosin-light-chain accumulation at the midbody and decreased levels of active RhoA during cytokinesis. The lack of RhoA activation in KIF3b-deficient cells was not rescued by overexpression of wild-type p0071 but was substantially ameliorated by a p0071-MKLP1-motor-domain fusion protein that was targeted to the furrow independently of KIF3. These data indicate that p0071 and Ect2 are transported via distinct motors and identify a novel pathway implicating KIF3 in the regulation of actin organization during cytokinesis.
P0071(斑联蛋白-4)是犰狳蛋白p120ctn亚家族的成员,这些蛋白对细胞接触的形成至关重要。此外,P0071在胞质分裂中发挥作用,在这一过程中它与Ect2共同调节RhoA的局部激活。由于胞质分裂的进行需要时空调节,我们分析了P0071何时以及如何靶向中体以诱导RhoA激活。我们发现Ect2在P0071在中体积累之前到达,并且靶向是由不同的运动蛋白介导的。P0071与驱动蛋白-II家族成员KIF3b相互作用,敲低KIF3b会干扰P0071在中体的募集,而在这些细胞中Ect2或RhoA的定位不受影响。此外,敲低KIF3b诱导出与敲低P0071类似的表型,中体处肌动蛋白和磷酸化肌球蛋白轻链的积累减少,胞质分裂期间活性RhoA水平降低。野生型P0071的过表达不能挽救KIF3b缺陷细胞中RhoA激活的缺失,但一种独立于KIF3靶向沟的P0071-MKLP1-运动结构域融合蛋白可显著改善这种情况。这些数据表明P0071和Ect2通过不同的运动蛋白运输,并确定了一条涉及KIF3在胞质分裂期间调节肌动蛋白组织的新途径。